File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Neuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemia

TitleNeuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemia
Authors
Issue Date2014
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk
Citation
The 19th Medical Research Conference, Department of Medicine, The University of Hong Kong, Hong Kong, China, 18 January 2014. In Hong Kong Medical Journal, 2014, v. 20 n. Suppl. 1, p. 18, abstract no. 19 How to Cite?
AbstractIntroduction: Melatonin is a potent-free radical scavenger and antioxidant. Previously, we have demonstrated beneficial effects of pretreatment with melatonin in mild and severe focal cerebral ischaemia in rodent models. Cerebral ischaemia increases intracellular Ca2+ concentrations, and activates several calcium-dependent proteases including calpain. Pretreatment with calpeptin, a novel calpain inhibitor, has been reported to reduce the cerebral infarct volume. In addition, it also decreases the neuronal apoptosis in hippocampal CA1 sector and improves the behavioural deficit in a rat stroke model. The aim of this study was to investigate the neuroprotective role of a post-ischaemia treatment with melatonin and / or calpeptin, and whether combining the two exerts synergistic or addictive effects in transient focal ischaemic stroke in rats. Methods: Male Sprague-Dawley rats (6-8 weeks) were anaesthetised with sodium pentobarbital to undergo right-sided endovascular middle cerebral artery occlusion (MCAO) for 90 minutes followed by 24 hours of reperfusion before being sacrificed. A single or a combined dose of melatonin (50 μg/kg) and / or calpeptin (50 μg/kg) were given via an intracerebroventricular injection at 10-15 minutes after onset of the reperfusion. Sham group with injection of vehicle only was used as a control group. Neurological behaviour was assessed using Neurological Deficit Scoring System (NDSS) test and cerebral infarction volumes were evaluated by TTCstaining. Results: Infarction volumes and NDSS scores were lower in the calpeptin group but not in melatonin group when compared with the control. The combining effects of melatonin and calpeptin will be studied further. Conclusion: Our results suggest that post-ischaemia treatment with calpeptin but not melatonin at 50 μg/kg protects against focal MCAO model in rats.
Persistent Identifierhttp://hdl.handle.net/10722/204268
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorFeng, Yen_US
dc.contributor.authorCheung, RTFen_US
dc.date.accessioned2014-09-19T21:43:13Z-
dc.date.available2014-09-19T21:43:13Z-
dc.date.issued2014en_US
dc.identifier.citationThe 19th Medical Research Conference, Department of Medicine, The University of Hong Kong, Hong Kong, China, 18 January 2014. In Hong Kong Medical Journal, 2014, v. 20 n. Suppl. 1, p. 18, abstract no. 19en_US
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/204268-
dc.description.abstractIntroduction: Melatonin is a potent-free radical scavenger and antioxidant. Previously, we have demonstrated beneficial effects of pretreatment with melatonin in mild and severe focal cerebral ischaemia in rodent models. Cerebral ischaemia increases intracellular Ca2+ concentrations, and activates several calcium-dependent proteases including calpain. Pretreatment with calpeptin, a novel calpain inhibitor, has been reported to reduce the cerebral infarct volume. In addition, it also decreases the neuronal apoptosis in hippocampal CA1 sector and improves the behavioural deficit in a rat stroke model. The aim of this study was to investigate the neuroprotective role of a post-ischaemia treatment with melatonin and / or calpeptin, and whether combining the two exerts synergistic or addictive effects in transient focal ischaemic stroke in rats. Methods: Male Sprague-Dawley rats (6-8 weeks) were anaesthetised with sodium pentobarbital to undergo right-sided endovascular middle cerebral artery occlusion (MCAO) for 90 minutes followed by 24 hours of reperfusion before being sacrificed. A single or a combined dose of melatonin (50 μg/kg) and / or calpeptin (50 μg/kg) were given via an intracerebroventricular injection at 10-15 minutes after onset of the reperfusion. Sham group with injection of vehicle only was used as a control group. Neurological behaviour was assessed using Neurological Deficit Scoring System (NDSS) test and cerebral infarction volumes were evaluated by TTCstaining. Results: Infarction volumes and NDSS scores were lower in the calpeptin group but not in melatonin group when compared with the control. The combining effects of melatonin and calpeptin will be studied further. Conclusion: Our results suggest that post-ischaemia treatment with calpeptin but not melatonin at 50 μg/kg protects against focal MCAO model in rats.-
dc.languageengen_US
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk-
dc.relation.ispartofHong Kong Medical Journalen_US
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleNeuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemiaen_US
dc.typeConference_Paperen_US
dc.identifier.emailCheung, RTF: rtcheung@hku.hken_US
dc.identifier.authorityCheung, RTF=rp00434en_US
dc.description.naturepublished_or_final_version-
dc.identifier.hkuros236233en_US
dc.identifier.volume20en_US
dc.identifier.issueSuppl. 1en_US
dc.identifier.spage18, abstract no. 19en_US
dc.identifier.epage18, abstract no. 19en_US
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats